Paracetamol ineffective against lower back pain, reveals study

GPs should reconsider advising patients to take paracetamol as the first-line treatment for lower back pain, after research that suggests its effects are 'no better than a placebo'.

Back pain: paracetamol no more effective than placebo, study suggests
Back pain: paracetamol no more effective than placebo, study suggests

Current NICE guidance pathways recommend regular paracetamol as the ‘first option’ for treating patients with lower back pain, despite a lack of any previous research indicating whether it is an effective way of treating the condition.

In the first large randomised study to assess the efficacy of paracetamol in alleviating lower back pain, a trial from the University of Sydney found that the analgesic had no effect in reducing any of its associated symptoms.

The Paracetamol for Low-Back Pain Study (PACE), published in the Lancet, studied 1,652 Australians with acute lower back pain and took place over four weeks.

A third of the participants were prescribed regular doses of paracetamol three times a day, another third were advised to take doses 'as needed' to manage pain and the remaining third were given a placebo.

No difference in recovery time, short-term pain levels, disability, function, sleep quality or quality of life was observed across each of these groups, suggesting the use of paracetamol was ineffective in alleviating any symptoms associated with lower back pain.

Further study required

The study authors said: ‘Our findings suggest that the efficacy of paracetamol should be carefully considered, with respect to the safe and effective use of medicines for low-back pain.’

They warned it was important for clinicians to wait for the results to be replicated before completely dismissing the use of paracetamol, especially given that alternative treatments have less favourable safety profiles.

They said: ‘Importantly, the safety profile of paracetamol is favourable compared with other analgesics recommended for low-back pain, e.g. NSAIDs. Because these other medicines have not been shown to provide additional benefit beyond that of paracetamol, and are only marginally better than placebo, it is not clear which drug should be preferred for management of low-back pain.’

Lead author Dr Christopher Williams said: ‘The results suggest we need to reconsider the universal recommendation to provide paracetamol as a first-line treatment for low-back pain, although understanding why paracetamol works for other pain states but not low-back pain would help direct future treatments.’

Low back pain is the leading cause of disability worldwide.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs demand 'early warning system' as drug shortages drive up workload

GPs demand 'early warning system' as drug shortages drive up workload

GP leaders have demanded an 'early warning system' to flag up medicine supply problems...

GPs need minimum 3.2% pay rise plus plan to reverse cuts, says BMA

GPs need minimum 3.2% pay rise plus plan to reverse cuts, says BMA

Pay for all doctors should rise by a minimum of 3.2% in 2019/20, the BMA has warned...

Solution to GP workforce crisis must come before NHS reform, MPs told

Solution to GP workforce crisis must come before NHS reform, MPs told

The workforce crisis and underfunding of general practice must be tackled before...

Multimorbidity: The gap between guidelines and the reality in practice

Multimorbidity: The gap between guidelines and the reality in practice

Delivering outcome-focused care to patients with comorbidities is increasingly problematic...

Doctors 'severely let down' by pay review body, warns BMA

Doctors 'severely let down' by pay review body, warns BMA

BMA leaders have demanded changes to the review process that sets GP pay, warning...

GP appointments data reveal year-on-year rise in workload

GP appointments data reveal year-on-year rise in workload

GP practices across England delivered nearly 500,000 more appointments in November...